4.5 Article

ZNF667-AS1, a positively regulating MEGF10, inhibits the progression of uveal melanoma by modulating cellular aggressiveness

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

The Role of Immune Checkpoint Blockade in Uveal Melanoma

Anja Wessely et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Regulation of the p53 expression profile by hnRNP K under stress conditions

Agata Swiatkowska et al.

RNA BIOLOGY (2020)

Article Neurosciences

Expression of MEGF10 in cholinergic and glutamatergic neurons

Yu Fujita et al.

NEUROSCIENCE LETTERS (2017)

Article Biotechnology & Applied Microbiology

valuation of p53 gene expression and prognosis characteristics in uveal melanoma cases

Haojie Liu et al.

ONCOTARGETS AND THERAPY (2017)

News Item Oncology

Fledglings in p53 signaling network

Takashi Tokino et al.

ONCOTARGET (2017)

Review Ophthalmology

Uveal melanoma: epidemiology, etiology, and treatment of primary disease

Benjamin A. Krantz et al.

CLINICAL OPHTHALMOLOGY (2017)

Article Biochemistry & Molecular Biology

A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers

Lukas Vrba et al.

EPIGENETICS (2015)

Review Oncology

Biology of cancer metastasis

Jacques Robert

BULLETIN DU CANCER (2013)

Article Ophthalmology

CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES

Carol L. Shields et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)

Article Ophthalmology

Uveal Melanoma: Trends in Incidence, Treatment, and Survival

Arun D. Singh et al.

OPHTHALMOLOGY (2011)

Article Biochemistry & Molecular Biology

MEGF10 functions as a receptor for the uptake of amyloid-β

Thoudam Debraj Singh et al.

FEBS LETTERS (2010)

Article Ophthalmology

Very long-term prognosis of patients with malignant uveal melanoma

E Kujala et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)